Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.64 USD | -6.67% | +8.66% | 0.00% |
May. 08 | Earnings Flash (CORZ) CORE SCIENTIFIC Posts Q1 Revenue $179.3M | MT |
May. 08 | Core Scientific, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CORZ Stock
- Ratings Core Scientific, Inc.